Clinical Development and Regulatory Affairs

The Clinical Development and Regulatory Affairs team at Enalare Therapeutics is responsible for designing and executing clinical trials to assess the safety and efficacy of novel therapies, including ENA-001. This team collaborates closely with regulatory agencies to ensure compliance with industry standards, facilitates the submission of regulatory documents, and oversees the development of drug formulations, ultimately supporting the company's goal of advancing innovative treatments for acute respiratory conditions.